13FPulse
中
AB

ABEO ABEONA THERAPEUTICS INC

2026Q2 · CUSIP 00289Y206 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
125
Institutions that reported holding it to the SEC
Net increase in holders
+20
Last quarter 105 → now 125
How unusual is that
Top 20%
Stronger buying than 83% of US stocks
What the filings say, in one paragraph

125 funds held ABEO at the end of 2026Q2, up 20 from the quarter before. That is stronger buying than 83.1% of US stocks — among the most piled-into names this quarter. On the business itself, return on equity is -49.1%. ABEO has had 2 buying rushes in its history, and the price moved -25.9% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2022Q3: holders=22 2022Q4: holders=41 2023Q1: holders=33 2023Q2: holders=37 2023Q3: holders=40 2023Q4: holders=48 2024Q1: holders=56 2024Q2: holders=48 2024Q3: holders=55 2024Q4: holders=64 2025Q1: holders=71 2025Q2: holders=94 2025Q3: holders=99 2025Q4: holders=103 2026Q1: holders=105 2026Q2: holders=125 -23 -11.5 +0 +11.5 +23 1976132 22Q323Q123Q324Q124Q325Q125Q326Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20% — —
2025Q2 Top 20% -35.6% -25.9%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
66
Change in large funds
+9
Total value they hold
$243M
Funds buying for the first time
35
Funds that sold out entirely
15
Price change that quarter
+10.2%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
5

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-1.11
EPS YoY
-182.8%
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-49.1%
Debt ratio
28.7%
FCF (TTM)
-$82M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2024-06-30: EPS -0.26 2024-09-30: EPS -0.63 2025-03-31: EPS -0.24 2025-06-30: EPS 1.71 2025-09-30: EPS -0.10 2025-12-31: EPS -0.36 2026-03-31: EPS -0.30 2026-06-30: EPS -0.35 -0.69 0.59 1.88 20242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
5 5 6 20252026

P/E = close around day 47 after quarter-end ÷ TTM EPS then; this is a consistent valuation date, not the company’s actual filing date; loss quarters hidden

Quarterly free cash flow
-34M-17M0K 20162017201820192020202120222023202420252026
Latest quarter $-21M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.